Written by students who passed Immediately available after payment Read online or as PDF Wrong document? Swap it for free 4.6 TrustPilot
logo-home
Document preview thumbnail
Preview 4 out of 52 pages
Exam (elaborations)

WGU D027 Advanced Pathopharmacological Foundations Pre-Assessment Exam Actual Exam 2026/2027 – Complete Exam-Style Questions | Detailed Rationales – Pass Guaranteed – A+ Graded

Document preview thumbnail
Preview 4 out of 52 pages

WGU D027 Advanced Pathopharmacological Foundations Pre-Assessment Exam Actual Exam 2026/2027 – Real-Style Questions with Answers | 100% Correct | Cellular Adaptation, Inflammation, Genetics, Neoplasia, Fluid/Electrolytes | Graded A+ Verified | Pharmacokinetics, Pharmacodynamics, Drug Classes, Adverse Effects, Drug Interactions | Detailed Rationales | Verified Correct Answers – Pass Guaranteed – Instant Download

Content preview

WGU D027 Pre-Assessment (Latest 2026/2027 Update) Advanced Pathopharmacological Foundations| Questions and Verified Answers| 100% Correct| Grade A
2026/2027 2026/2027 | Page 1 | Passing Score: 80%




WESTERN GOVERNORS UNIVERSITY
WGU D027 Pre-Assessment (Latest 2026/2027 Update) Advanced
Pathopharmacological Foundations| Questions and Verified
Answers| 100% Correct| Grade A 2026/2027
ADVANCED PATHOPHARMACOLOGICAL FOUNDATIONS · Official Exam
2026/2027



100 80% CERTIFIED
QUESTIONS PASSING SCORE RECERTIFICATION




TABLE OF CONTENTS



Section 1 Pathophysiology of Cellular and Tissue Disorders Q1-20


Section 2 Pharmacokinetics, Pharmacodynamics, and Drug Therapy Q21-40


Section 3 Cardiovascular and Hematologic Pathopharmacology Q41-60


Section 4 Neurological and Psychiatric Pathopharmacology Q61-80


Section 5 Immune, Endocrine, and Respiratory Pathopharmacology Q81-100



Instructions: Select the single best answer for each question. This exam is designed for WGU D027 Advanced Pathopharmacological
Foundations pre-assessment preparation. Passing score: 80% (80 questions correct).




WGU D027 Pre-Assessment (Latest 2026/2027 Update) Advanced Pathopharmacological Foundations| Questions and Verified Answers| 100% Correct| Grade A
2026/2027 2026/2027 | Passing Score: 80% | Page 1 of 52

, SECTION 1 | Pathophysiology of Cellular and Tissue Disorders | Q1-Q20 | WGU D027 Pre-Assessment (Latest 2026/2027 Update)
Advanced Pathopharmacological Foundations| Questions and Verified Answers| 100% Correct| Grade A 2026/2027 2026/2027


Q1 Question 1 of 100
A 55-year-old man with a 30-pack-year smoking history presents with a persistent cough and
weight loss. A lung biopsy reveals cells with large, irregular nuclei and abnormal mitotic figures.
Which cellular adaptation best describes the initial change that preceded malignant transformation?
A. Metaplasia of bronchial epithelium from columnar to squamous type
B. Hyperplasia of alveolar cells
C. Hypertrophy of bronchial smooth muscle
D. Dysplasia of bronchial epithelium

Correct Answer: D
Rationale:
Dysplasia, characterized by abnormal, disorganized cell growth with atypical nuclei and mitotic figures, is the
direct precursor to malignant transformation. Metaplasia is a reversible change from one cell type to another that
may precede dysplasia but is not the immediate precursor. Hyperplasia and hypertrophy are adaptive, not
pre-malignant changes.




Q2 Question 2 of 100
A 40-year-old woman presents with fatigue, pallor, and a hemoglobin of 7.8 g/dL. Peripheral smear
shows microcytic, hypochromic red blood cells. Iron studies reveal low serum ferritin. Which
pathophysiologic mechanism best explains her anemia?
A. Impaired heme synthesis due to insufficient iron for ferrochelatase activity
B. Decreased erythropoietin production by the kidneys
C. Increased red blood cell destruction by the spleen
D. Bone marrow failure reducing erythroid progenitor cells

Correct Answer: A
Rationale:
Iron deficiency anemia results from insufficient iron to support heme synthesis, specifically the
ferrochelatase-catalyzed insertion of iron into protoporphyrin IX. This produces microcytic, hypochromic cells.
Decreased EPO causes normocytic anemia in kidney disease. Splenic destruction causes hemolytic anemia.
Bone marrow failure causes pancytopenia.




WGU D027 Pre-Assessment (Latest 2026/2027 Update) Advanced Pathopharmacological Foundations| Questions and Verified Answers| 100% Correct| Grade A
2026/2027 2026/2027 | Passing Score: 80% | Page 2 of 52

, Q3 Question 3 of 100
A 60-year-old man with chronic alcohol abuse presents with jaundice, ascites, and elevated liver
enzymes. A liver biopsy shows hepatocytes with swollen, pale cytoplasm containing Mallory
bodies. Which cellular injury mechanism is most likely occurring?
A. Apoptosis mediated by caspase activation
B. Coagulative necrosis from ischemia
C. Fatty degeneration with intracellular protein accumulation
D. Caseous necrosis from granulomatous inflammation

Correct Answer: C
Rationale:
Mallory bodies (eosinophilic cytoplasmic inclusions) are a hallmark of alcoholic liver disease, representing
intracellular accumulation of damaged intermediate filaments in hepatocytes undergoing fatty degeneration.
Apoptosis does not produce Mallory bodies. Coagulative necrosis preserves tissue architecture. Caseous
necrosis is associated with tuberculosis.




Q4 Question 4 of 100
A 35-year-old woman presents with a butterfly rash across her cheeks and nasal bridge. Laboratory
tests reveal positive ANA and anti-dsDNA antibodies. Which pathophysiologic process is the
primary mechanism driving her disease?
A. Type I hypersensitivity reaction with IgE-mediated mast cell degranulation
B. Type II hypersensitivity with antibody-dependent cellular cytotoxicity
C. Type III hypersensitivity with immune complex deposition in tissues
D. Type IV hypersensitivity with T-cell-mediated tissue damage

Correct Answer: C
Rationale:
Systemic lupus erythematosus is primarily driven by type III hypersensitivity, where autoantibodies form immune
complexes that deposit in tissues (skin, kidneys, joints), activating complement and causing inflammation. The
butterfly rash and anti-dsDNA antibodies are characteristic. Type I involves allergies, type II involves cell
destruction, and type IV is T-cell mediated.




WGU D027 Pre-Assessment (Latest 2026/2027 Update) Advanced Pathopharmacological Foundations| Questions and Verified Answers| 100% Correct| Grade A
2026/2027 2026/2027 | Passing Score: 80% | Page 3 of 52

, Q5 Question 5 of 100
A 68-year-old man with atherosclerosis suffers a myocardial infarction. After 24 hours, histologic
examination of the infarcted tissue would most likely reveal which finding?
A. Coagulative necrosis with preservation of tissue architecture
B. Liquefactive necrosis with complete enzymatic digestion
C. Caseous necrosis with granuloma formation
D. Fat necrosis with saponification

Correct Answer: A
Rationale:
Myocardial infarction produces coagulative necrosis, characterized by preservation of tissue architecture with
denatured proteins maintaining cell outlines, typically evident by 12-24 hours. Liquefactive necrosis occurs in the
brain. Caseous necrosis is seen in tuberculosis. Fat necrosis occurs in pancreatic tissue and breast fat.




Q6 Question 6 of 100
A 45-year-old man with cirrhosis develops increased abdominal girth and edema. Paracentesis
reveals a serum-ascites albumin gradient greater than 1.1 g/dL. Which mechanism primarily
contributes to ascites formation in portal hypertension?
A. Splanchnic arteriolar vasodilation triggering activation of the renin-angiotensin-aldosterone system
B. Decreased hepatic lymphatic drainage alone
C. Malignant peritoneal seeding with exudative fluid
D. Protein-losing enteropathy causing hypoalbuminemia

Correct Answer: A
Rationale:
In cirrhosis, portal hypertension causes splanchnic arteriolar vasodilation, which reduces effective arterial blood
volume and activates the RAAS, leading to sodium and water retention and ascites formation. While lymphatic
drainage is impaired, vasodilation and RAAS activation are the primary drivers. Malignancy causes exudative
ascites. Protein-losing enteropathy is a separate condition.




WGU D027 Pre-Assessment (Latest 2026/2027 Update) Advanced Pathopharmacological Foundations| Questions and Verified Answers| 100% Correct| Grade A
2026/2027 2026/2027 | Passing Score: 80% | Page 4 of 52

Document information

Uploaded on
June 2, 2026
Number of pages
52
Written in
2025/2026
Type
Exam (elaborations)
Contains
Questions & answers
$17.49

Wrong document? Swap it for free Within 14 days of purchase and before downloading, you can choose a different document. You can simply spend the amount again.
Written by students who passed
Immediately available after payment
Read online or as PDF

Seller avatar
Reputation scores are based on the amount of documents a seller has sold for a fee and the reviews they have received for those documents. There are three levels: Bronze, Silver and Gold. The better the reputation, the more your can rely on the quality of the sellers work.
STUVIAACTUALEXAMS
3.5
(168)
Sold
1268
Followers
209
Items
9272
Last sold
12 hours ago




Why students choose Stuvia

Created by fellow students, verified by reviews

Quality you can trust: written by students who passed their tests and reviewed by others who've used these notes.

Didn't get what you expected? Choose another document

No worries! You can instantly pick a different document that better fits what you're looking for.

Pay as you like, start learning right away

No subscription, no commitments. Pay the way you're used to via credit card and download your PDF document instantly.

Student with book image

“Bought, downloaded, and aced it. It really can be that simple.”

Alisha Student

Working on your references?

Create accurate citations in APA, MLA and Harvard with our free citation generator.

Working on your references?

Frequently asked questions